Nonpharmacological Treatment of Cognitive Impairment
نویسندگان
چکیده
منابع مشابه
Nonpharmacological treatment of postmenopausal symptoms
Learning objectives To review the current nonpharmacological agents that are available for the treatment of postmenopausal symptoms. To review nonpharmacological options for prevention of diseases that occur at an increased incidence after menopause. Ethical issues While hormone replacement therapy is highly effective in the treatment of postmenopausal symptoms, it is associated with health ris...
متن کاملNonpharmacological treatment of Alzheimer disease.
OBJECTIVE To review the key nonpharmacological treatment approaches to the cognitive and functional symptoms of Alzheimer disease (AD). METHODS We searched and critically analyzed the most recent relevant literature pertaining to the nonpharmacological treatment of AD. RESULTS There is evidence from a modest number of well-conducted randomized controlled trials (RCTs) that various nonpharma...
متن کاملLate-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions
Less than half of older adults with depression achieve remission with antidepressant medications, and rates of remission are even poorer for those with comorbid conditions. Psychosocial interventions have been effective in treating geriatric depression, either alone or better yet, in combination with antidepressant medications. Traditional strategies for nonpharmacological treatment of late-lif...
متن کاملEffects of sound pillow in the treatment of stuttering and cognitive phonemes impairment in children
Introduction:Verbal language is Fundamental component for expressing ideas, social interaction and understanding educational materials. Effective communications require verbal language skills. Sound pillows may partly address the children with behavior problems. The purpose of this study was assessing the effect of educational sound pillow in the treatment of stuttering and cognitive phonemes i...
متن کاملThe treatment of cognitive impairment in schizophrenia.
Cognitive deficits are major contributors to disability in schizophrenia. Many pharmacologic targets have been identified for cognitive enhancing agents, including receptors involved in dopaminergic, glutamatergic, GABAergic, serotonergic and cholinergic neurotransmission. In addition, new approaches to drug development have been directed towards neuroprotection and the facilitation of neuropla...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The journal of nutrition, health & aging
سال: 2018
ISSN: 1279-7707,1760-4788
DOI: 10.1007/s12603-018-1036-2